Conducted on fully differentiated human nasal tissue using the MucilAir™ model, the study demonstrated ... is intended to remain in the nasal cavity for approximately 4 hours post-application.

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Conducted on fully differentiated human nasal tissue using the MucilAir™ model, the study demonstrated strong local ... PL-14 Allergy Blocker is intended to remain in the nasal cavity for ...

Human brains are great at sorting through a barrage of sensory information—like discerning the smell of tomato sauce upon ...

The size and number of polyps directly correlate with breathing difficulty severity, with some people developing extensive “polyposis” that transforms the entire nasal cavity. Smaller polyps ...